Banque Cantonale Vaudoise - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Banque Cantonale Vaudoise ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
930.0%0.00%
Q1 2022$1,0000.0%930.0%0.00%
Q4 2021$1,000
-99.7%
93
-99.7%
0.00%
-100.0%
Q3 2021$329,000
-30.0%
36,537
-6.9%
0.01%
-33.3%
Q2 2021$470,000
-7.8%
39,250
-3.5%
0.02%
-19.2%
Q1 2021$510,000
-33.3%
40,694
-17.0%
0.03%
-38.1%
Q4 2020$765,000
+252.5%
49,039
+113.7%
0.04%
+200.0%
Q3 2020$217,000
+6.9%
22,951
+1.2%
0.01%
-6.7%
Q2 2020$203,000
+55.0%
22,668
+10.6%
0.02%
+36.4%
Q1 2020$131,000
-30.3%
20,490
-8.8%
0.01%
-15.4%
Q4 2019$188,00022,4740.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,032,980$12,950,0001.82%
EcoR1 Capital, LLC 2,308,079$14,702,0001.54%
Alexandria Capital, LLC 1,005,119$6,403,0001.05%
Casdin Capital, LLC 1,455,000$9,268,0000.98%
Rhenman & Partners Asset Management AB 700,000$4,459,0000.62%
Bellevue Group AG 3,850,000$24,525,0000.48%
GREAT POINT PARTNERS LLC 633,505$4,035,0000.42%
WASATCH ADVISORS LP 5,938,434$37,828,0000.39%
361 CAPITAL LLC 109,161$695,0000.32%
Ceeto Capital Group, LLC 50,000$319,0000.26%
View complete list of SANGAMO THERAPEUTICS INC shareholders